Experiments with dextran sulphate as an anticoagulant.
作者信息
WALTON K
出版信息
Proc R Soc Med. 1951 Jul;44(7):563-4. doi: 10.1177/003591575104400710.
Abstract
摘要
相似文献
1
Experiments with dextran sulphate as an anticoagulant.
Proc R Soc Med. 1951 Jul;44(7):563-4. doi: 10.1177/003591575104400710.
2
3
Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol.
Br Med J. 1956 Nov 3;2(5000):1023-7. doi: 10.1136/bmj.2.5000.1023.
4
The blood anticoagulant effect of short chain-length dextran sulphates.
Br J Pharmacol Chemother. 1954 Jun;9(2):224-8. doi: 10.1111/j.1476-5381.1954.tb00845.x.
5
[Inhibition of coagulant principles in snake venoms by dextran sulfate, a synthetic anticoagulant of bacterial origin].
Schweiz Z Pathol Bakteriol. 1954;17(4):514-20.
6
[Thromboelastographic studies of the anticoagulant action in vivo of dextran sulfate].
Prog Med (Napoli). 1958 Mar 31;14(6):167-71.
7
Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
Bull Exp Biol Med. 2017 Feb;162(4):462-465. doi: 10.1007/s10517-017-3640-2. Epub 2017 Feb 27.
8
The use of dextran sulphate as a blood anticoagulant in biological research.
J Clin Pathol. 1952 Nov;5(4):366. doi: 10.1136/jcp.5.4.366.
9
The anticoagulant activity and toxicity of dextran sulphate and a xylan polysulphuric acid.
Scand J Clin Lab Invest. 1955;7(3):204-11. doi: 10.3109/00365515509134511.
10
The anticoagulant activity of dextran sulphate. II. The effect of dextran sulphate on the one-stage prothrombin time.
J Pharm Pharmacol. 1956 Aug;8(8):589-601. doi: 10.1111/j.2042-7158.1956.tb12190.x.
引用本文的文献
1
Transient stealth coating of liver sinusoidal wall by anchoring two-armed PEG for retargeting nanomedicines.
Sci Adv. 2020 Jun 26;6(26):eabb8133. doi: 10.1126/sciadv.abb8133. eCollection 2020 Jun.
2
Dextran sulphate--a synthetic analogue of heparin.
Biochem J. 1952 Apr;51(1):129-33. doi: 10.1042/bj0510129.
3
A heparin-precipitable fraction of human plasma. I. Isolation and characterization of the fraction.
J Clin Invest. 1957 Apr;36(4):596-604. doi: 10.1172/JCI103459.
4
Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol.
Br Med J. 1956 Nov 3;2(5000):1023-7. doi: 10.1136/bmj.2.5000.1023.
5
Investigation of the toxicity of a series of dextran sulphates of varying molecular weight.
Br J Pharmacol Chemother. 1954 Mar;9(1):1-14. doi: 10.1111/j.1476-5381.1954.tb00809.x.
6
Dextran sulphate: the relation of molecular features to biological properties.
Br J Pharmacol Chemother. 1953 Dec;8(4):476-7. doi: 10.1111/j.1476-5381.1953.tb01351.x.
7
Experimental physiology of a heart-lung machine in parallel with normal circulation.
Br Med J. 1953 Jul 11;2(4827):62-6. doi: 10.1136/bmj.2.4827.62.
8
The use of dextran sulphate as a blood anticoagulant in biological research.
J Clin Pathol. 1952 Nov;5(4):366. doi: 10.1136/jcp.5.4.366.
9
The biological behaviour of a new synthetic anticoagulant (dextran sulphate) possessing heparin-like properties.
Br J Pharmacol Chemother. 1952 Sep;7(3):370-91. doi: 10.1111/j.1476-5381.1952.tb00705.x.
Zotero 插件